Description
2-Methylmethcathinone (2-MMC, ortomephedrone) is a recreational designer drug with stimulant and euphoric effects. It is a substituted cathinone derivative, closely related to better known drugs such as 3-methylmethcathinone and 4-methylmethcathinone (mephedrone).[2][3] It was first identified in Sweden in 2014,[4] and has subsequently been reported in other European countries such as Poland[5] and Spain.[6]
Reviews
There are no reviews yet.